Executive functioning at ages 5 and 7 years in children with prenatal cocaine exposure

Developmental Neuroscience

Volumn 31, Issue 1-2, 2009, Pages 121-136

  Eyler, Fonda Davis ^a,c   Warner, Tamara Duckworth ^d   Behnke, Marylou ^a   Hou, Wei ^b   Wobie, Kathleen ^a   Garvan, Cynthia Wilson ^c  

^a College of Medicine ^*  (United States)

^b Department of Clinical and Health Psychology   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Children; Cocaine exposure, prenatal; Executive functioning

Indexed keywords

COCAINE;

ARTICLE; CHILD; CONTROLLED STUDY; DEPRESSION; FEMALE; GESTATIONAL AGE; GROUPS BY AGE; HEAD CIRCUMFERENCE; HUMAN; MALE; PERINATAL DRUG EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STRUCTURED INTERVIEW; URINALYSIS;

AFRICAN CONTINENTAL ANCESTRY GROUP; CAREGIVERS; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COCAINE; DATA INTERPRETATION, STATISTICAL; ENVIRONMENT; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOMOTOR PERFORMANCE; SEX CHARACTERISTICS; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 65349095648     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000207500     Document Type: Article

References (121)

1. Farrar HC, Kearns GL: Cocaine: clinical pharmacology and toxicology. J Pediatr 1989; 115: 665-675.
2. Eyler FD, Behnke M: Early development of infants exposed to drugs prenatally. Clin Perinatol 1999; 26: 107-150.
3. Mayes LC: Neurobiology of prenatal cocaine exposure effect on developing monoamine systems. Infant Ment Health J 1994; 15: 121-133.
4. Dow-Edwards DL: Developmental toxicity of cocaine: mechanisms of action; in Lewis M, Bendersky M (eds): Mothers, Babies, and Cocaine: The Role of Toxins in Development. Hillsdale, Lawrence Erlbaum Associates, 1995, pp 5-17.
5. Levitt P, Harvey JA, Friedman E, Simansky K, Murphy EH: New evidence for neurotransmitter influences on brain development. Trends Neurosci 1997; 20: 269-274.
6. Whitaker-Azmitia PM: Role of the neurotrophic properties of serotonin in the delay of brain maturation induced by cocaine. Ann NY Acad Sci 1998; 846: 158-164.
7. Harvey JA: Cocaine effects on the developing brain: current status. Neurosci Biobehav Rev 2004; 27: 751-764.
8. Lidow MS: Consequences of prenatal cocaine exposure in nonhuman primates. Dev Brain Res 2003; 147: 23-36.
9. Lauder JM: Discussion: neuroteratology of cocaine-relationship to developing monoamine systems; in Kilbey MM, Ashgar J (eds): Methodological Issues in Controlled Studies on Effects of Prenatal Exposure to Drug Abuse (NIDA Research Monograph No. 114). Bethesda, National Institute on Drug Abuse 1991, pp 233-247.
10. Woods JR Jr: Adverse consequences of prenatal illicit drug exposure. Curr Opin Obstet Gynecol 1996; 8: 403-411.
11. Mayes LC: Developing brain and in utero cocaine exposure: effects on neural ontogeny. Dev Psychopathol 1999; 11: 685-714.
12. Malanga CJ, Kosofsky BE: Mechanisms of action of drugs of abuse on the developing fetal brain. Clin Perinatol 1999; 26: 17-37.
13. Spear LP: Alterations in cognitive functioning following prenatal cocaine exposure: studies in an animal model; in Lewis M, Bendersky M (eds): Mothers, Babies, and Cocaine: The Role of Toxins in Development. Hillsdale, Erlbaum, 1995, pp 207-227.
14. Vorhees CV: A review of developmental exposure models for CNS stimulants: cocaine; in Lewis M, Bendersky M (eds): Mothers, Babies, and Cocaine: The Role of Toxins in Development. Hillsdale, Lawrence Erlbaum Associates, 1995, pp 71-94.
15. Morris P, Gillam MP, Allen RR, Paule MG: The effect of chronic cocaine exposure during pregnancy on the acquisition of operant behaviors by rhesus monkey offspring. Neurotoxicol Teratol 1996; 18: 155-166.
16. Gabriel M, Taylor C: Prenatal exposure to cocaine impairs neuronal coding of attention and discriminative learning. Ann NY Acad Sci 1998; 846: 194-212.
17. Wilkins AS, Genova LM, Posten W, Kosofsky BE: Transplacental cocaine exposure. 1. A rodent model. Neurotoxicol Teratol 1998; 20: 215-226.
18. Garavan H, Morgan RE, Mactutus CF, Levitsky DA, Booze RM, Strupp BJ: Prenatal cocaine exposure impairs selective attention: evidence from serial reversal and extradimensional shift tasks. Behav Neurosci 2000; 114: 725-738.
19. Stanwood GD, Levitt P: Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development. Curr Opin Pharmacol 2004; 4: 65-71.
20. Chiriboga C, Brust J, Bateman D, Hauser A: Dose response effect of fetal cocaine exposure on newborn neurologic function. Pediatrics 1999; 103: 79-80.
21. Coles CD, Bard KA, Platzman KA, Lynch ME: Attentional response at eight weeks in prenatally drug-exposed and preterm infants. Neurotoxicol Teratol 1999; 21: 527-537.
22. Swanson MW, Streissguth AP, Sampson PD, Olson HC: Prenatal cocaine and neuromotor outcome at four months: effect of duration of exposure. J Dev Behav Pediatr 1999; 20: 325-334.
23. Bard KA, Coles CD, Platzman KA, Lynch ME: The effects of prenatal drug exposure, term status, and caregiving on arousal and arousal modulation in 8-week-old infants. Dev Psychobiol 2000; 36: 194-212.
24. Singer LT, Arendt R, Minnes S, Farkas K, Salvator A: Neurobehavioral outcomes of cocaine-exposed infants. Neurotoxicol Teratol 2000; 22: 653-666.
25. Morrow CE, Bandstra ES, Anthony JC, Ofir AY, Xue L, Reyes ML: Influence of prenatal cocaine exposure on full-term infant neurobehavioral functioning. Neurotoxicol Teratol 2001; 23: 533-544.
26. Lester BM, Tronick EZ, LaGasse L, Seifer R, Bauer CR, Shankaran S, Bada HS, Wright LL, Smeriglio VL, Liu J, Finnegan LP, Maza PL: The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics 2002; 110: 1182-1192.
27. Lester BM, Lagasse L, Seifer R, Tronick EZ, Bauer CR, Shankaran S, Bada HS, Wright LL, Smeriglio VL, Liu J, Finnegan LP, Maza PL: The Maternal Lifestyle Study (MLS): effects of prenatal cocaine and/or opiate exposure on auditory brain response at one month. J Pediatr 2003; 142: 279-285.
28. Schuetze P, Eiden RD: The association between maternal cocaine use during pregnancy and physiological regulation in 4-to 8-week-old infants: an examination of possible mediators and moderators. J Pediatr Psychol 2006; 31: 15-26.
29. Schuetze P, Eiden RD, Coles CD: Prenatal cocaine and other substance exposure: effects on infant autonomic regulation at 7 months of age. Dev Psychobiol 2007; 49: 276-289.
30. Thyssen Van Beveren T, Little BB, Spence MJ: Effects of prenatal cocaine exposure and postnatal environment on child development. Am J Human Biol 2000; 12: 417-428.
31. Singer LT, Arendt R, Minnes S, Farkas K, Salvator A, Kirchner HL, Kliegman R: Cognitive and motor outcomes of cocaine-exposed infants. JAMA 2002; 287: 1952-1960.
32. Chiriboga CA, Kuhn L, Wasserman GA: Prenatal cocaine exposures and dose-related cocaine effects on infant tone and behavior. Neurotoxicol Teratol 2007; 29: 323-330.
33. Bennett DS, Bendersky M, Lewis M: Children's intellectual and emotional-behavioral adjustment at 4 years as a function of cocaine exposure, maternal characteristics, and environmental risk. Dev Psychol 2002; 38: 648-658.
34. Dennis T, Bendersky M, Ramsay D, Lewis M: Reactivity and regulation in children prenatally exposed to cocaine. Dev Psychol 2006; 42: 688-697.
35. Noland JS, Singer LT, Short EJ, Minnes S, Arendt RE, Kirchner HL, Bearer C: Prenatal drug exposure and selective attention in preschoolers. Neurotoxicol Teratol 2005; 27: 429-438.
36. Hurt H, Malmud E, Betancourt LM, Brodsky NL, Giannetta JM: A prospective comparison of developmental outcome of children with in utero cocaine exposure and controls using the Battelle Developmental Inventory. J Dev Behav Pediatr 2001; 22: 27-34.
37. Richardson GA, Conroy ML, Day NL: Prenatal cocaine exposure: effects on the development of school-age children. Neurotoxicol Teratol 1996; 18: 627-634.
38. Delaney-Black V, Covington C, Templin T, Kershaw T, Nordstrom-Klee B, Ager J, Clark N, Surendran A, Martier S, Sokol RJ: Expressive language development of children exposed to cocaine prenatally: literature review and report of a prospective cohort study. J Commun Disord 2000; 33: 463-480.
39. Hurt H, Giannetta J, Brodsky NL, Malmud E, Pelham T: Are there neurologic correlates of in utero cocaine exposure at age 6 years? J Pediatr 2001; 138: 911-913.
40. Arendt RE, Short EJ, Singer LT, Minnes S, Hewitt J, Flynn S, Carlson L, Min MO, Klein N, Flannery D: Children prenatally exposed to cocaine: developmental outcomes and environmental risks at seven years of age. J Dev Behav Pediatr 2004; 25: 83-90.
41. Pulsifer MB, Radonovich K, Belcher HM, Butz AM: Intelligence and school readiness in preschool children with prenatal drug exposure. Child Neuropsychol 2004; 10: 89-101.
42. Singer LT, Minnes S, Short E, Arendt R, Farkas K, Lewis B, Klein N, Russ S, Min MO, Kirchner HL: Cognitive outcomes of preschool children with prenatal cocaine exposure. JAMA 2004; 291: 2448-2456.
43. Frank DA, Rose-Jacobs R, Beeghly M, Wilbur M, Bellinger D, Cabral H: Level of prenatal cocaine exposure and 48-month IQ: importance of preschool enrichment. Neurotoxicol Teratol 2005; 27: 15-28.
44. Morrow CE, Culbertson JL, Accornero VH, Xue L, Anthony JC, Bandstra ES: Learning disabilities and intellectual functioning in school-aged children with prenatal cocaine exposure. Dev Neuropsychol 2006; 30: 905-931.
45. Hurt H, Brodsky NL, Roth H, Malmud E, Giannetta JM: School performance of children with gestational cocaine exposure. Neurotoxicol Teratol 2005; 27: 203-211.
46. Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment, ed 4. New York, Oxford University Press, 2004.
47. Gioia GA, Isquith PK, Kenworthy L, Barton RM: Profiles of everyday executive function in acquired and developmental disorders. Child Neuropsychol 2002; 8: 121-137.
48. Leech SL, Richardson GA, Goldschmidt L, Day NL: Prenatal substance exposure: effects on attention and impulsivity of 6-year olds. Neurotoxicol Teratol 1999; 21: 109-118.
49. Bandstra ES, Morrow CE, Anthony JC, Accornero VH, Fried PA: Longitudinal investigation of task persistence and sustained attention in children with prenatal cocaine exposure. Neurotoxicol Teratol 2001; 23: 545-559.
50. Savage J, Brodsky NL, Malmud E, Giannetta JM, Hurt H: Attentional functioning and impulse control in cocaine-exposed and control children at age ten years. J Dev Behav Pediatr 2005; 26: 42-47.
51. Accornero VH, Amado AJ, Morrow CE, Xue L, Anthony JC, Bandstra ES: Impact of prenatal cocaine exposure on attention and response inhibition as assessed by continuous performance tests. J Dev Behav Pediatr 2007; 28: 195-205.
52. Bendersky M, Gambini G, Lastella A, Bennett DS, Lewis M: Inhibitory motor control at five years as a function of prenatal cocaine exposure. J Dev Behav Pediatr 2003; 24: 345-351.
53. Reitan RM, Wolfson D: The Halstead-Reitan Neuropsychological Test Battery: Theory and Interpretation. Tucson, Neuropsychology Press, 1985.
54. Warner TD, Behnke M, Eyler FD, Padgett K, Leonard C, Hou W, Garvan CW, Schmalfuss IM, Blackband SJ: Diffusion tensor imaging of frontal white matter and executive functioning in cocaine-exposed children. Pediatrics 2006; 118: 2014-2024.
55. Golden CJ, Freshwater SM, Golden Z: Stroop Color and Word Test Children's Version for ages 5-14: A Manual for Clinical and Experimental Uses. Wood Dale, Stoelting Company, 2003.
56. Mayes LC, Molfese DL, Key AP, Hunter NC: Event-related potentials in cocaine-exposed children during a Stroop task. Neurotoxicol Teratol 2005; 27: 797-813.
57. Eyler FD, Behnke M, Conlon M, Woods NS, Wobie K: Birth outcome from a prospective, matched study of prenatal crack/cocaine use: I. Interactive and dose effects on health and growth. Pediatrics 1998; 101: 229-236.
58. Vorhees CV: Concepts in teratology and developmental toxicology derived from animal research. Ann NY Acad Sci 1989; 562: 31-41.
59. Sameroff AJ, Chandler MJ: Reproductive risk and the continuum of caretaking casualty; in Horowitz FD (ed): Review of Child Development Research. Chicago, University of Chicago Press, 1975, pp 187-244.
60. Downey G, Coyne JC: Children of depressed parents: an integrative review. Psychol Bull 1990; 108: 50-76.
61. The course of maternal depressive symptoms, maternal sensitivity, and child outcomes. NICHD Early Child Care Research Network. Dev Psychol 1999; 35: 1297-1310.
62. Brennan PA, Hammen C, Andersen MJ, Bor W, Najman JM, Williams GM: Chronicity, severity, and timing of maternal depressive symptoms: relationships with child outcomes at age 5. Dev Psychol 2000; 36: 759-766.
63. Campbell SB, Matestic P, von Stauffenberg C, Mohan R, Kirchner T: Trajectories of maternal depressive symptoms, maternal sensitivity, and children's functioning at school entry. Dev Psychol 2007; 43: 1202-1215.
64. Menaghan EG, Parcel TL: Determining children's home environments: the impact of maternal characteristics and current occupational and family conditions. J Marriage Fam 1991; 53: 417-431.
65. Judge TA, Erez A, Bono JE, Thoresen CJ: Are measures of self-esteem, neuroticism, locus of control, and generalized self-efficacy indicators of a common core construct? J Pers Soc Psychol 2002; 83: 693-710.
66. Bradley RH, Tedesco L: Environmental correlates of mental retardation; in Lachenmeyer J, Gibbs M (eds): The Psychology of the Abnormal Child. New York, Gardner, 1982, pp 155-189.
67. Parke R: Children's home environments: social and cognitive effects; in Altman I, Wohlhill J (eds): Children and the Environment. New York, Plenum, 1978, pp 107-119.
68. Bradley RH, Corvyn RF, Burchinal M, Mc-Adoo HP, Coll CG: The home environments of children in the United States. II. Relations with behavioral development through age thirteen. Child Dev 2001; 72: 1868-1886.
69. Eyler FD, Behnke M, Conlon M, Woods NS, Frentzen B: Prenatal cocaine use: a comparison of neonates matched on maternal risk factors. Neurotoxicol Teratol 1994; 16: 81-87.
70. Mule SJ, Casella GA: Confirmation of marijuana, cocaine, morphine, codeine, amphetamine, methamphetamine, phencyclidine by GC/MS in urine following immunoassay screening. J Anal Toxicol 1988; 12: 102-107.
71. Day NL, Wagener DK, Taylor PM: Measurement of substance use during pregnancy: methodologic issues. NIDA Res Monogr 1985; 59: 36-47.
72. Behnke M, Eyler FD, Conlon M, Wobie K, Woods NS, Cumming W: Incidence and description of structural brain abnormalities in cocaine-exposed newborns. J Pediatr 1998; 132: 291-294.
73. Eyler FD, Behnke M, Garvan C, Woods N, Wobie K, Conlon M: Newborn evaluations of toxicity and withdrawal related to prenatal cocaine exposure. Neurotoxicol Teratol 2001; 23: 399-411.
74. Behnke M, Eyler FD, Woods NS, Wobie K, Conlon M: Rural pregnant cocaine users: an in-depth sociodemographic comparison. J Drug Issues 1997; 27: 501-525.
75. Wobie K, Eyler FD, Garvan CW, Hou W, Behnke M: Prenatal cocaine exposure: an examination of out-of-home placement during the first year of life. J Drug Issues 2004; 34: 77-94.
76. Wechsler D: Manual for the Wechsler Preschool and Primary Scale of Intelligence -Revised. San Antonio, The Psychological Corporation, 1989.
77. Hooper EH: Hooper Visual Organization Test. Los Angeles, Western Psychology Services, 1965.
78. Wechsler D: Manual for the Wechsler Intelligence Scale for Children, ed 3. San Antonio, The Psychological Corporation, 1991.
79. Reitan RM, Wolfson D: The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation, ed 2. Tucson, Neuropsychology Press, 1993.
80. Behnke M, Eyler FD, Garvan C, Wobie K, Marron J: The relationship of outcome to commonly used quantitative assessments of prenatal cocaine use. Pediatr Res 1999; 45: 1394A.
81. Woods NS, Behnke M, Eyler FD, Conlon M, Wobie K: Cocaine use among pregnant women: socioeconomic, obstetrical, and psychological issues; in Lewis M, Bendersky M (eds): Mothers, Babies, and Cocaine: The Role of Toxins in Development. Hillsdale, Lawrence Erlbaum Associates, 1995, pp 305-332.
82. Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Appl Pscyhol Meas 1977; 1: 385-401.
83. Comstock GW, Helsing KJ: Symptoms of depression in two communities. Psychol Med 1976; 6: 551-563.
84. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ: Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1977; 106: 203-214.
85. Levenson H: Activism and powerful others: distinctions within the concept of internalexternal control. J Pers Assess 1974; 38: 377-383.
86. Rotter JB: Generalized expectancies for internal versus external control of reinforcement. Psychol Monogr 1966; 80: 1-28.
87. Brown BR, Granick S: Cognitive and psychosocial differences between I and E locus of control aged persons. Exp Aging Res 1983; 9: 107-110.
88. Lefcourt HM, Martin RA, Fick CM, Saleh WE: Locus of control for affiliation and behavior in social interactions. J Pers Soc Psychol 1985; 48: 755-759.
89. Johnson JH, Sarason IG: Life stress, depression and anxiety: internal-external control as a moderator variable. J Psychosom Res 1978; 22: 205.
90. Edwards JE, Waters LK: Relationships of locus of control to academic ability, academic performance, and performance-related attributions. Educ Psychol Meas 1981; 41: 529-531.
91. Stringer S, La Greca A: Correlates of child abuse potential. J Abnorm Child Psychol 1985; 13: 217-226.
92. Cutrona CE, Troutman BR: Social support, infant temperament, and parenting self-efficacy: a mediational model of postpartum depression. Child Dev 1986; 57: 1507-1518.
93. Gibaud-Wallston J: Self-esteem and situational stress: factors related to sense of competence in new parents. Diss Abstr Int 1977; 39: 379B.
94. Wandersman LP, Wandersman A, Kahn S: Social support in the transition to parenthood. J Community Psychol 1980; 8: 332-342.
95. Caldwell BM, Bradley BH: Home Observation for Measurement of the Environment. Little Rock, University of Arkansas Press, 1984.
96. Bradley RH: The HOME Inventory: review and reflections; in Reese H (ed): Advances in Child Development and Behavior. San Diego, Academic Press, 1994, pp 241-288.
97. Bradley RH, Corvyn RF, Whiteside-Mansell L: Life at home: same time, different places. An examination of the HOME Inventory in different cultures. Early Dev Parent 1996; 5: 251-269.
98. Bradley RH, Corvyn RF, Burchinal M, Mc-Adoo HP, Coll CG: The home environments of children in the United States. II. Relations with behavioral development through age 13. Child Dev 2001; 72: 1868-1886.
99. Bradley RH, Caldwell BM: Home observation for measurement of the environment: a revision of the preschool scale. Am J Ment Defic 1979; 84: 235-244.
100. Bradley RH, Caldwell BM, Rock SL, Hamrick HM, Harris P: Home Observation for Measurement of the Environment: development of a home inventory for use with families having children 6 to 10 years old. Contemp Educ Psychol 1988; 13: 58-71.
101. Ullman JB: Structural equation modeling; in Tabachnick BG, Fidell LS (eds): Using Multivariate Statistics, ed 4. Boston, Allyn & Bacon, 2001, pp 653-771.
102. Little TD, Lindenberger U, Nesselroade JR: On selecting indicators for multivariate measurement and modeling with latent variables: when 'good' indicators are bad and 'bad' indicators are good. Psychol Methods 1999; 4: 192-211.
103. Bentler PM: Comparative fit indexes in structural models. Psychol Bull 1990; 107: 238-246.
104. Hu LT, Bentler PM: Fit indices in covariance structure modeling: sensitivity to underparameterized model misspecification. Psychol Methods 1998; 3: 424-453.
105. Hu LT, Bentler PM: Cutoff criteria for fit indices in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model 1999; 6: 1-55.
106. McDonald RP: An index of goodness-offit based on noncentrality. J Classification 1989; 6: 97-103.
107. MacCallum RC, Austin JT: Applications of structural equation modeling in psychological research. Annu Rev Psychol 2000; 51: 201-226.
108. MacCallum RC, Browne MW, Sugawara HM: Power analysis and determination of sample size for covariance structure modeling. Psychol Methods 1996; 1: 130-149.
109. Behnke M, Eyler FD, Garvan CW, Wobie K, Hou W: Cocaine exposure and developmental outcome from birth to 6 months. Neurotoxicol Teratol 2002; 24: 283-295.
110. Behnke M, Eyler FD, Warner TD, Garvan CW, Hou W, Wobie K: Outcome from a prospective, longitudinal study of prenatal cocaine use: preschool development at 3 years of age. J Pediatr Psychol 2006; 31: 41-49.
111. Frisk V, Amsel R, Whyte HE: The importance of head growth patterns in predicting the cognitive abilities and literacy skills of small-for-gestational- age children. Dev Neuropsychol 2002; 22: 565-593.
112. Ounsted M, Moar VA, Scott A: Head circumference and developmental ability at the age of seven years. Acta Paediatr Scand 1988; 77: 374-379.
113. Azuma SD, Chasnoff IJ: Outcome of children prenatally exposed to cocaine and other drugs: a path analysis of three-year data. Pediatrics 1993; 92: 396-402.
114. Betancourt L, Fischer R, Giannetta J, Malmud E, Brodsky NL, Hurt H: Problem solving ability of inner-city children with and without in utero cocaine exposure. J Dev Behav Pediatr 1999; 20: 418-424.
115. Johnson AL, Morrow CE, Accornero VH, Xue L, Anthony JC, Bandstra ES: Maternal cocaine use: estimated effects on motherchild play interactions in the preschool period. J Dev Behav Pediatr 2002; 23: 191-202.
116. Bendersky M, Bennett D, Lewis M: Aggression at age 5 as a function of prenatal exposure to cocaine, gender, and environmental risk. J Pediatr Psychol 2006; 31: 71-84.
117. Accornero VH, Morrow CE, Bandstra ES, Johnson AL, Anthony JC: Behavioral outcome of preschoolers exposed prenatally to cocaine: role of maternal behavioral health. J Pediatr Psychol 2002; 27: 259-269.
118. Linares TJ, Singer LT, Kirchner HL, Short EJ, Min MO, Hussey P, Minnes S: Mental health outcomes of cocaine-exposed children at 6 years of age. J Pediatr Psychol 2006; 31: 85-97.
119. Accornero VH, Anthony JC, Morrow CE, Xue L, Bandstra ES: Prenatal cocaine exposure: an examination of childhood externalizing and internalizing behavior problems at age 7 years. Epidemiol Psichiatr Soc 2006; 15: 20-29.
120. Delaney-Black V, Covington C, Templin T, Ager J, Nordstrom-Klee B, Martier S, Leddick L, Czerwinski RH, Sokol RJ: Teacherassessed behavior of children prenatally exposed to cocaine. Pediatrics 2000; 106: 782-791.
121. Bada HS, Das A, Bauer CR, Shankaran S, Lester B, LaGasse L, Hammond J, Wright LL, Higgins R: Impact of prenatal cocaine exposure on child behavior problems through school age. Pediatrics 2007; 119: e348-e359.